Showing results (221-230 of 484) with videos related to

Sort By:
Pageof 49
Japanese Journal of Cancer Research : Gann|February 25, 1998
The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitroT Takahashi, Y Fujiwara, M Yamakido, et al.
Toxicology and Applied Pharmacology|September 15, 2004
Regulation of UDP glucuronosyltransferases in the gastrointestinal tractPhilip A Gregory, Rikke H Lewinsky, Dione A Gardner-Stephen, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2017
Exemestane and Its Active Metabolite 17-Hydroexemestane Induce UDP-Glucuronosyltransferase (UGT) 2B17 Expression in Breast Cancer CellsApichaya Chanawong, Peter I Mackenzie, Ross A McKinnon, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 26, 2009
Amyloid reduction by amyloid-beta vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's diseaseDonna M Wilcock, Nastaran Gharkholonarehe, William E Van Nostrand, et al.
BMC Neuroscience|February 4, 2005
Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic miceChad A Dickey, Marcia N Gordon, Donna M Wilcock, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 16, 2003
Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7Andrew N Stone, Peter I Mackenzie, Aleksandra Galetin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 1998
Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3M D Green, C D King, B Mojarrabi, et al.
Pageof 49